These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9639449)

  • 1. Retinal vessel changes in galactose-fed dogs.
    Kobayashi T; Kubo E; Takahashi Y; Kasahara T; Yonezawa H; Akagi Y
    Arch Ophthalmol; 1998 Jun; 116(6):785-9. PubMed ID: 9639449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabeteslike preproliferative retinal changes in galactose-fed dogs.
    Takahashi Y; Wyman M; Ferris F; Kador PF
    Arch Ophthalmol; 1992 Sep; 110(9):1295-302. PubMed ID: 1520120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent retinal capillary pericyte degeneration in galactose-fed dogs.
    Kador PF; Takahashi Y; Akagi Y; Blessing K; Randazzo J; Wyman M
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):63-9. PubMed ID: 17341153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aldose reductase inhibitors and galactose withdrawal on fluorescein angiographic lesions in galactose-fed dogs.
    Cusick M; Chew EY; Ferris F; Cox TA; Chan CC; Kador PF
    Arch Ophthalmol; 2003 Dec; 121(12):1745-51. PubMed ID: 14662595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs.
    Kador PF; Takahashi Y; Akagi Y; Neuenschwander H; Greentree W; Lackner P; Blessing K; Wyman M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1916-21. PubMed ID: 12036999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabeteslike proliferative retinal changes in galactose-fed dogs.
    Kador PF; Takahashi Y; Wyman M; Ferris F
    Arch Ophthalmol; 1995 Mar; 113(3):352-4. PubMed ID: 7887849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aldose reductase inhibitors on the progression of retinopathy in galactose-fed dogs.
    Akagi Y; Kador PF
    Exp Eye Res; 1990 Jun; 50(6):635-9. PubMed ID: 2115453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the vascular targeting agent combretastatin a-4 prodrug on retinal neovascularization in the galactose-fed dog.
    Kador PF; Blessing K; Randazzo J; Makita J; Wyman M
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):132-42. PubMed ID: 17444801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors.
    Kador PF; Akagi Y; Takahashi Y; Ikebe H; Wyman M; Kinoshita JH
    Arch Ophthalmol; 1990 Sep; 108(9):1301-9. PubMed ID: 2119169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactose-induced retinal microangiopathy in rats.
    Kern TS; Engerman RL
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Neuenschwander H; Takahashi Y; Kador PF
    J Ocul Pharmacol Ther; 1997 Dec; 13(6):517-28. PubMed ID: 9436155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of diabetes-like retinal changes in galactose-fed dogs.
    Kador PF; Takahashi Y; Sato S; Wyman M
    Prev Med; 1994 Sep; 23(5):717-21. PubMed ID: 7845946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia.
    Engerman RL; Kern TS
    Arch Ophthalmol; 1995 Mar; 113(3):355-8. PubMed ID: 7887850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats.
    Kern TS; Engerman RL
    Curr Eye Res; 1994 Dec; 13(12):863-7. PubMed ID: 7720392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors.
    Kador PF; Akagi Y; Terubayashi H; Wyman M; Kinoshita JH
    Arch Ophthalmol; 1988 Aug; 106(8):1099-102. PubMed ID: 3401138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
    Frank RN; Amin R; Kennedy A; Hohman TC
    Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of retinal vessel changes in galactose-fed dogs.
    Takahashi Y; Augustin W; Wyman M; Kador PF
    J Ocul Pharmacol; 1993; 9(3):257-69. PubMed ID: 8228533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.
    Tolentino MJ; Miller JW; Gragoudas ES; Jakobiec FA; Flynn E; Chatzistefanou K; Ferrara N; Adamis AP
    Ophthalmology; 1996 Nov; 103(11):1820-8. PubMed ID: 8942877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic correlations in diabetic retinopathy. II. Clinical and histologic appearances of retinal capillary microaneurysms.
    Bresnick GH; Davis MD; Myers FL; de Venecia G
    Arch Ophthalmol; 1977 Jul; 95(7):1215-20. PubMed ID: 880082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.